Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Undefined

ABSTRACT: Bladder microbiota in bladder cancer and controls

PROVIDER: PRJEB61079 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR11276100_1.fastq.gz	Fastqsanger.gz
	ERR11276100_2.fastq.gz	Fastqsanger.gz
	ERR11276101_1.fastq.gz	Fastqsanger.gz
	ERR11276101_2.fastq.gz	Fastqsanger.gz
	ERR11276102_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 202

Similar Datasets

Therapeutic inhibition of METTL3/miR-146a-5p-guided NOTCH pathway suppresses bladder cancer progression

Project description:Bladder cancer characterized by RNA methylation abnormalities and NOTCH pathway dysregulation exhibits high recurrence that remains the major obstacle for bladder cancer treatment. Targeting methyltransferase-like 3 (METTL3) and NOTCH signal is a potential strategy to block bladder cancer progression. However, the underlying mechanisms by which METTL3-manipulated NOTCH signal and its effect on bladder cancer tumorigenesis remain to be clarified. Here we showed that METTL3-guided m6A modification methylated pri-miR-146 at the flaking sequence, which was responsible for the pri-miR-146 maturation. Furthermore, NUMB/NOTCH2 axis was identified as the functional downstream target signal that mediated the pro-survival role of miR-146a-5p in bladder cancer cells. Therapeutically, the polypeptide melittin was demonstrated to induce apoptosis of bladder cancer cells in a METTL3-dependent manner. Importantly, METTL3 and miR-146a-5p were positively correlated with recurrence and poor prognosis of bladder cancer patient. Our studies indicate that METTL3/miR-146a-5p/NUMB/NOTCH2 axis could be a potential therapeutic target for recurrent bladder cancer treatment and METTL3 acts as a fate determinant that controls sensitivity of bladder cancer cells to melittin treatment.

2024-10-01 | GSE185272 | GEO

Urinary microbiota and bladder cancer

Project description:Urinary microbiota and bladder cancer

| PRJEB39977 | ENA

Project description:Bladder and kidney cancer microbiota

| PRJNA988250 | ENA

Project description:URINARY MICROBIOTA AND BLADDER CANCER

| PRJNA659223 | ENA

Project description:RRBS on Bladder Cancer samples and controls

| PRJNA715028 | ENA

Bladder cancer expression profiling

Project description:Cystoscopic bladder biopsies were obtained from 19 patients and 11 controls between 2004 and 2005. Whole transcript based arrays were used to identify differences in expression profile between cancer and normal, muscle-invasive or non-muscle invasive cancer and normal, grade 1 and grade 3 bladder cancer.

2014-07-01 | E-MTAB-1560 | biostudies-arrayexpress

Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer

Project description:Objective was to identify urine cell-free microRNAs enabling early non-invasive detection of bladder cancer. Total RNA enriched for fraction of short RNAs was isolated using Urine microRNA purification kit (Norgen corp.). miRNA profiles were determined using the Affymetrix GeneChip miRNA 3.0 array and analyzed to identify differentially deregulated miRNA in bladder cancer patients compared with helathy controls.

2017-10-29 | E-MTAB-6102 | biostudies-arrayexpress

Muscular invasiveness in bladder cancer

Project description:Patients with bladder cancer need frequent controls over long follow-up time due to high recurrence rate and risk of conversion to muscle invasive cancer with poor prognosis. We identified cancer-related molecular signatures in apparently healthy bladder in patients with subsequent muscular invasiveness during follow-up. Global proteomics of the normal tissue biopsies revealed specific proteome fingerprints in these patients prior to subsequent muscular invasiveness. In these presumed normal samples, we detected modulations of proteins previously associated with different cancer types. This study indicates that analyzing apparently healthy tissue of a cancer-invaded organ may predict disease progression.

2018-10-26 | PXD010260 | Pride

urine of bladder cancer and controls

Project description:urine of bladder cancer and controls Raw sequence reads

| PRJNA486651 | ENA

Project description:Role of microbiota in bladder cancer development

| PRJNA1119950 | ENA